S. aureus Enterotoxin Type B Toxoid (DAGB111) This product is for research use only and is not intended for diagnostic use.
PRODUCT INFORMATION
Antigen Description Staphylococcal enterotoxins B (SEB) is described as a superantigen for its ability to bind to Major Histocompatibility Complex molecules on antigen presenting cells and stimulate a large population of T cells, producing an inappropriate flood of cytokines. Although they are important participants in an immune response, cytokines, when overproduced, lead to toxic shock. Recently SEB has been found to bind to another regulator of the T cell immune response, CD 28. When added to human peripheral blood cells, SEB produces large quantities of IL-2, TNF-A and INF-c. Native SEB toxin has been treated with formaldehyde to produce a toxoid which has reduced cytokine stimulating activity and immunogenicity when compared with the native toxin. Care must be taken in the design of experiments with the toxoid because although toxicity has been reduced, sufficient toxicity may remain to cause death under certain conditions. Both the toxin and toxoid are handled as Select Agents and Toxins.
Nature Native
Expression System S. aureus
Species S. aureus
Conjugate Unconjugated
Applications ELISA
Reconstitution When reconstituted with 500 μl water, contains 250 μg of Staphylococcal Enterotoxin Type B Toxoid in 0.1M Histidine, 0.1M Sodium Chloride, pH 7.0, with 5% Trehalose.
Endotoxin The endotoxin content, determined using a kinetic chromogenic LAL assay, is approximately 2 EU/mg.
Procedure None
Format Lyophilized power
Size 0.25 mg
Preservative None
Storage Store at 2-8°C prior to reconstitution. Following reconstitution, aliquot and freeze.
45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected]
Tel: 1-631-624-4882 Fax: 1-631-938-8221 1 © Creative Diagnostics All Rights Reserved